tiprankstipranks
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF

Defence Therapeutics (DTCFF) Technical Analysis

9 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Defence Therapeutics’s (DTCFF) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Defence Therapeutics is a Sell.
Defence Therapeutics’s (DTCFF) 20-Day exponential moving average is 0.67, while Defence Therapeutics’s (DTCFF) share price is $0.6, making it a Sell.
Defence Therapeutics’s (DTCFF) 50-Day exponential moving average is 0.81, while Defence Therapeutics’s (DTCFF) share price is $0.6, making it a Sell.

Defence Therapeutics (DTCFF) Pivot Points

Jul 08, 2024, 02:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.62
0.62
0.62
0.62
0.62
0.62
0.62
Fibonacci
0.62
0.62
0.62
0.62
0.62
0.62
0.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Defence Therapeutics (DTCFF) Moving Averages

Jul 08, 2024, 02:31 AM
Period
Simple
Exponential
MA5
0.60Sell
0.61Sell
MA10
0.60Sell
0.62Sell
MA20
0.67Sell
0.67Sell
MA50
0.81Sell
0.81Sell
MA100
1.05Sell
1.03Sell
MA200
1.45Sell
1.40Sell
Defence Therapeutics’s (DTCFF) 10-Day exponential moving average is 0.62, while Defence Therapeutics’s (DTCFF) share price is $0.6, making it a Sell.
Defence Therapeutics’s (DTCFF) 100-Day exponential moving average is 1.03, while Defence Therapeutics’s (DTCFF) share price is $0.6, making it a Sell.
Defence Therapeutics’s (DTCFF) stock price is $0.6 and Defence Therapeutics’s (DTCFF) 50-day simple moving average is 0.81, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.6 and Defence Therapeutics’s (DTCFF) 100-day simple moving average is 1.05, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.6 and Defence Therapeutics’s (DTCFF) 200-day simple moving average is 1.45, creating a Sell signal.

Defence Therapeutics (DTCFF) Technical Indicators

Jul 08, 2024, 02:31 AM
Name
Value
Implied Action
RSI (14)
41.51
Neutral
STOCH (9,6)
49.30
Neutral
STOCHRSI (14)
38.54
Neutral
MACD (12,26)
-0.07
Sell
ADX (14)
9.96
Buy
Williams %R
-62.13
Buy
CCI (14)
-68.00
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
46.54
Neutral
ROC
-15.49
Sell
Defence Therapeutics’s (DTCFF) Relative Strength Index (RSI) is 41.51, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Trend Strength Indicator (ADX) is 9.96, creating a Buy signal.
Defence Therapeutics’s (DTCFF) Commodity Channel Index (CCI) is -68.00, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Price Rate of Change (ROC) is -15.49, creating a Sell signal.

FAQ

Is DTCFF a Buy, Hold, or Sell?
Based on DTCFF’s technical indicators, DTCFF is a Strong Sell.
    What is DTCFF’s RSI (14)?
    DTCFF’s RSI (14) is 41.51, which suggests DTCFF is a Neutral.
      What is DTCFF’s MACD?
      DTCFF’s MACD is -0.07, which suggests DTCFF is a Sell.
        What is DTCFF’s 5-day moving average?
        DTCFF’s 5-day moving average is 0.60, which suggests DTCFF is a Sell.
          What is DTCFF’s 20-day moving average?
          DTCFF 20-day moving average is 0.67, which suggests DTCFF is a Sell.
            What is DTCFF’s 50-day moving average?
            DTCFF’s 50-day moving average is 0.81, which suggests DTCFF is a Sell.
              What is DTCFF’s 200-day moving average?
              DTCFF’s 200-day moving average is 1.45, which suggests DTCFF is a Sell.
                What is DTCFF’s Williams % R (14)?
                DTCFF’s Williams % R (14) is -62.13, which suggests DTCFF is a Buy.
                  What is DTCFF’s CCI (14)?
                  DTCFF’s CCI (14) is -68.00, which suggests DTCFF is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis